Typical incumbent platform range, before procedure consumables.
Robotics in every operating room.
Aevum is developing a compact, lower-complexity surgical robotics platform designed around real operating-room workflows and wider access to advanced care.
Surgical robotics is stuck at the top of the market.
Today's leading systems deliver precision, but their cost, footprint, infrastructure and training burden keep adoption concentrated in large, top-tier hospitals. The next platform must make capability easier to deploy.
Certification and workflow change before clinical use.
Dedicated space, setup time and supporting infrastructure.
Less invasive. More precise. Now, more accessible.
Robotics advanced precision. Aevum is focused on the next constraint: delivering that capability through compact, streamlined architecture.
Robotic capability, radically simplified.
The system is conceived as a smaller-footprint platform with streamlined architecture, intuitive control and the robotic capabilities surgeons actually need.
Built around operating-room workflow and the patient side.
Designed around surgeons and existing clinical practice.
Integrated drive architecture for controlled instrument motion.
Only the hardware and infrastructure required for clinical value.
Visible simplicity, designed into every detail.
Each view has a job: system context first, then patient-side interaction, instrument geometry and the actuation architecture beneath it.
A clear set of values, designed into every decision.
Robotics in every operating room is the vision. Compactness, lower complexity, less-invasive capability and surgeon-centred workflow are how Aevum intends to achieve it.
Robotics in Every Operating Room
Democratize access by making surgical robotics deployable at operating-room scale, rather than a scarce hospital-level resource.
Compact Architecture
A smaller footprint and streamlined architecture designed around the realities of the operating room.
Lower System Complexity
Reduce unnecessary hardware and infrastructure while retaining the robotic capabilities surgeons actually need.
Purpose-Built for Less-Invasive Surgery
Dexterity and articulation optimized for constrained-access procedures such as SILS, TAMIS and NOTES/VNOTES.
Surgeon-Centred Design
Intuitive control and workflow designed around surgeons and existing clinical practice.
PolyU × Peking University Third Hospital
Medicine–Engineering Collaborative Innovation Research Laboratory. Memorandum of understanding signed January 2025.
Anchored at one of China's top hospitals.
The validation pathway brings engineering development and clinical input together from the beginning, with a route to additional Hong Kong and Greater Bay Area sites as the program scales.
Faculty of Engineering partnership and technical collaboration.
Department of General Surgery clinical pathway aligned with the NMPA strategy.
Additional Hong Kong and GBA clinical sites as evidence develops.
A capital-efficient path to first-in-human.
The seed program funds the MVP, activates the PolyU collaboration and creates the evidence base for the next stage.
HKD 3M seed and company formation.
PolyU program launch and integrated prototype.
Validation, quality system and pathway confirmation.
Clinical studies and regulatory submissions.
Hong Kong first, then the GBA and wider markets.
Surgical robotics depth. Globally recognized design.
A founding team spanning industrial design, electrical engineering, mechanical engineering and clinical product development.
Alan Kwok
Founder & Project Coordinator15+ years across medical robotics and product innovation, with experience taking surgical platforms to clinical trials.
Sotiris Tsouris
Industrial Designer12+ years in industrial design, including award-winning surgical and medical products.
Kenric Lam
Electrical Engineer30+ years in engineering and more than eight years of surgical robotics experience.
Ka Wai
Mechanical EngineerMechanical development across instrument design, integrated actuation and design for manufacture.
Let's build the future of surgery.
Aevum is raising a focused seed round to deliver the MVP, activate the PolyU program and open the larger clinical and funding pathway.